跳至主要内容
临床试验/NCT05811689
NCT05811689已完成不适用

Trabecular Bone Score (TBS) as an Innovative Parameter Evaluation for Bone Disease's in Multiple Sclerosis (MS) Patients and Impact of Osteoporosis on the Quality of Life of Patients With MS

IRCCS Centro Neurolesi "Bonino-Pulejo"1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年2月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
1
主要终点
DXA scanner (Horizon© DXA System)

研究概览

简要总结

Assess bone quality in MS patients through TBS and evaluate the potential effects exerted by different drugs used in MS treatment, which may affect BMD and TBS in MS patients

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of MS according to the latest revision of McDonald's criteria;
  • patients with relapsing-remitting MS (RRMS), secondary progressive MS (SPMS) and primary progressive MS (SPMS);
  • absence of cortisone therapy for at least 6 months;

排除标准

  • patients already being treated with anti-osteoporotic drugs;
  • medical conditions that preclude the execution of the densitometric examination

结局指标

主要结局

DXA scanner (Horizon© DXA System)

时间窗: 6 months

The DXA scanner (Horizon© DXA System) measures bone mineral content relative to bone area.

次要结局

  • Bone Mineral Density(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验